Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing

The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol’s native token.

Related Posts

Leave a Reply

Recent Articles

Tokenization demand is no longer tied to Bitcoin: Galaxy executive
November 13, 2025
Sour crypto mood could fuel an unexpected rally this month: Santiment
November 13, 2025
Vitalik Buterin champions decentralization in ‘Trustless Manifesto’
November 13, 2025

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Post Category